AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CIPROFLOXACIN USP

12 registrations across 4 African markets— 5 active

Markets with CIPROFLOXACIN USP

Recent registrations

Brand / ProductMarketHolderStatusExpires
Aarciflox-500
Film-coated tablets,
🇷🇼RwandaAARTI DRUGS LIMITED.activeFeb 2031
Ciprofloxacin IV
Solution for Intravenous Infusion
🇷🇼RwandaPHARCO B INTERNATIONALactiveSept 2030
Q-Bact tablets
Tablet, Filmcoated
🇿🇲ZambiaSaga Lifesciences LimitedactiveNov 2029
CIPROCIN
OPHTHALMIC SOLUTION
🇷🇼RwandaAbacus Parenteral Drugs Ltd (APDL)activeAug 2029
ULTRAFLOX-500
Film Coated Tablets
🇷🇼RwandaBAL PHARMA LIMITEDactiveJul 2029
DORPROFLUX INJECTION
1 X 100ML
🇳🇬NigeriaDORGLORY PHARM LTD 32expiredMar 2022
GECIP INJECTION 200MG
INJECTION/1X100ML
🇳🇬NigeriaGENEITH PHARMA LTD 14AexpiredApr 2021
CIPROXACT TABLET
TABLET/1X10
🇳🇬NigeriaTAUREAN PHARMACEUTICAL LTD 2C OCONNOR STREETexpiredApr 2021
CIPLOX 2MG/ML INJECTION
INJECTION
🇲🇼MalawiexpiredJun 2012
ZOXAN 0.3%W/V EAR/EYE DROPS
EAR/EYE DROPS
🇲🇼MalawiexpiredJun 2006
CEBRAN-500 500MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2006
CEBRAN-250 250MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2006

CIPROFLOXACIN USP in Africa — Regulatory Overview

CIPROFLOXACIN USP is registered across 4 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 5 (42%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.